NFE2L3 and bladder transitional cell carcinoma: Importantly, intervention in NFE2L3 expression suppressed the progression of BLCA, potentially through the regulation of NFE2L3 in the cell cycle, apoptosis, and EMT (Qian et al., 2022), indicating that NFE2L3 is involved in the advancement of BLCA.